









































Pa
ge

 
1



Pa
ge

 
53

American Journal of  Medical 
Science and Innovation (AJMSI) 

Artificial Intelligence Applications in the Diagnosis and Treatment of  
Bacterial Infections

Sarabjit Kaur1*

Volume 4 Issue 2, Year 2025
ISSN: 2836-8509 (Online)

DOI: https://doi.org/10.54536/ajmsi.v4i2.5420
https://journals.e-palli.com/home/index.php/ajmsi

Article Information ABSTRACT

Received: June 28, 2025
Accepted: July 30, 2025
Published: September 13, 2025

In today’s era Artificial Intelligence (AI) is the fruitful and informative tool to treat the 
bacterial infections. AI features provide the outcomes more effectively, accurately, manifest 
the disease parameters in shorter period of  time which results in safe and potential life. 
Knowledge Engineering (KE)-based approaches have confirmed in cost-effective, reduce 
dependency on particular structure and detect the bacterial infection by various mode 
of  testing machines like antimicrobial susceptibility testing (AST) by leveraging machine 
learning models, Support Vector Machines (SVM), and deep learning architectures such 
as Convolutional Neural Networks (CNNs) and transformers. Thus, it also enables the 
bacterial detection through Smartphone-integrated platforms and telemedicine applications. 
These integrated platforms will help in the research of  drugs and vaccines that can use in the 
antibiotics resistance treatment. Furthermore, AI technology has a widespread deployment 
in detection of  the bacterial resistance strains, transforming the bacterial infection. Its 
algorithms can easier analyze various data sources like genomic data, clinical data and 
capture of  proper image helps to identify the different bacterial species and strains. AI also 
assist in the applications of   laboratory diagnostics and clinical microbiology to recognize 
the Gram Positive Or Gram Negative bacteria by plate counting, mass spectrometry for 
example, MALDI-TOF MS data which accurately classifies different Staphylococcus aureus 
subspecies. Morphology-based and motion-based microscopic detection, holographic 
microscopy, colorimetric and fluorescence detection, electrochemical sensors, Raman and 
Surface-Enhanced Raman Spectroscopy (SERS), and Atomic Force Microscopy (AFM) and 
AST all these methodologies help in bacterial diagnosis, offering improved precision, reduce 
the time period between sampling and result resolution. It is very useful novel technique in 
finding the new antibiotics and to localize the site of  action that is directly deliver the drug 
to the targeted site.  AI tool act as a right hand for medical researchers, doctors, nurses that 
provide best result to overcome the challenges in bacterial infection cure, reduced the side 
effects; improves patient –compliance and promote healthy life with proper personalization.

Keywords
Artificial Intelligence, Bacterial 
Diagnostics, Bacterial Infections, 
Knowledge Engineering, MALDI-
TOF, Personalization

1 Guru Nanak Institute of  Pharmacy, Dalewal, India
* Corresponding author’s e-mail: sarabkhuttan@gmail.com

INTRODUCTION 
Millions of  the people died due to the bacterial infection 
every year. Researchers had claimed bacterial infections 
are one of  the causes of  people death after the heart 
attack. Accurate and proper investigation of  pathogens 
and suitable drug is vital for the treatment of  bacterial 
infection. Bacterial infections are classify by the shape 
of  bacteria such as bacilli, cocci, spirochetes and vibrio 
whether they are Gram positive or Gram negative and 
aerobic or anaerobic. These types help the physician for 
selection of  suitable drugs and vaccines. Long term use 
of  board spectrum antibiotics can lead to resistance. 
At the same time, surveillance and management of  
bacterial infections are essential to prevent their spread 
and safeguard public health. So, AI is the novel technique 
that offers several applications in order to cure the 
bacterial infection caused by tuberculosis, STIs (sexually 
transmitted infections), lungs, skin, urinary tract infection 
(UTI), GIT and respiratory infections. The fast expansion 
of  AI will result in the positive therapeutic effect in curing 
the bacterial infections. 
Artificial Intelligence (AI) is the tool which works like a 

computer or machine to perform task in a simple way with 
the help of  human intelligence such as object learning, 
thinking, creativity, innovating the idea, problem-solving 
and understanding language. AI is the powerful technique 
that helps in the identification, diagnosis, prevention and 
treatment of  bacterial infections. Furthermore, AI helps 
the developers and experimenter in the formation of  new 
drugs, vaccines and targeted delivery to the cell, tissue 
and organs.  Machine learning, also helps in studying the 
drug and excipients profile, structure activity relationship 
(SAR) in drug development. It helps to predict bioactivity 
of  compounds with the target ligands, proteins or site by 
using the QSAR modeling and molecular docking. SAR 
play vital role in knowing efficacy and potency of  drug 
while selectively reducing the toxicity of  drug candidates. 
Machine learning determines the bacterial infection by 
using automatic and identification of  pathogen. It can also 
analyze by images, data resources obtained from genomic, 
clinical samples (Blood, urine, stool etc), experiments, 
laboratory tests and public health database. Apart from 
this, morphology-based and motion-based microscopic 
detection, holographic microscopy, colorimetric and 



Pa
ge

 
54

https://journals.e-palli.com/home/index.php/ajmsi

Am. J. Med. Sci. Innov. 4(2) 53-72, 2025

fluorescence detection, electrochemical sensors, Raman 
and Surface-Enhanced Raman Spectroscopy (SERS), 
and Atomic Force Microscopy (AFM) and AST all 

these methodologies help in bacterial diagnosis, offering 
improved precision, reduce the time period between 
sampling and result resolution.

Table 1: How AI work out to cure the bacterial infection?
Invention of  New Drug AI algorithms can easily investigate the chemical structures features and their bioactivities 

to predict the productivity of  new drug candidates against resistant bacteria. AI also 
identifies the potential of  new antibiotics at what percentage it can stop or kill the 
bacterial infection.

Detection of  Pathogens With the help of  AI-powered tools one can easily identify the bacterial pathogens, 
even those that are resistant to antibiotics. This allows for more targeted and effective 
treatment options.

Streamlined treatment 
plans

Developers with the aid of  AI can examine patient data to know individual responses of  
different antibiotics and customized treatment which provides patients compliance by 
reducing the risk of  side effects and alternative treatment for antibiotic resistance therapy.

SAR Analysis 1. Drug activity prediction: AI models help the researchers to rundown the drug and 
excipients. By studying the different sites of  structure one can know the active site that 
act against bacterial infection.
2. Emphasizing key structural properties : 
AI helps in identifying the configurationally properties of  drug that is biological activity 
which result to design more effective drugs. 
3. Improving drug development efficiency: AI can assist in designing new drugs by 
predicting the effects of  modifications to a drug's structure, which can lead to the 
development of  more potent and selective drugs. 

Personalization AI can analyze user data to understand the person behaviors, taste that will enables in the 
tailored experience.  

Optimizing Drug 
Delivery

AI can be used for optimizing the  route  and site of  delivery of  antibiotics  infection, 
thus improving the therapeutic effect and minimizing the side effects. 

Figure 1: Artificial intelligence facilitates the diagnosis of  bacterial infectious diseases

Firstly, let us know how bacterial infection occurs. It 
occurs when the harmful or toxic substances enter in the 
body and interfering in immune system.Thus, decreasing 
the body defense system to work against diseases. Skin 
cuts, uncovered wounds, contaminated  food or  water, 

inbreathe of  droplets from the infected person, infected 
blood fluids, direct explore to the contaminated surfaces 
and then touch it with mouth, eyes  or anywhere on the 
body can lead to bacterial infection. So, with the help of  
Artificial intelligence these problems can be solved.



Pa
ge

 
55

https://journals.e-palli.com/home/index.php/ajmsi

Am. J. Med. Sci. Innov. 4(2) 53-72, 2025

Bacteria when cause the infection generally attacks on 
epithelial cells, although it affects the various types of  cells 
present in the body. Epithelial cells that is responsible for 
the formation of  lining of  many organs and tissues, target 
most as they are present between the internal tissues and 
external environment. In addition, macrophages and 
neutrophils (part of  immune defense system) are also 
affected. As we already know bacterial infections spread 
through various mode of  mechanisms- contaminated 
food and water, by air, direct interact with the infection 
etc can cause various types of  diseases like adhesion, 

toxins, invasiveness, evading the immune system. So, AI is 
the most powerful tool to detect which type of  infection 
and which treatment must be best for the patient. 
Artificial intelligence (AI) has control the disease that is 
increasing the rapid diagnosis and antibiotic discovery. As 
conventional criteria of  detection takes long time.  
By AI methods like machine learning, deep learning and 
computer vision one can finds the type of  pathogens or 
chronic bacterial infection for which someone couldn’t 
find the treatment to cure.

Figure 2: depicts that different mode of  AI diagnosis process 

Figure 3: illustrate the shape of  the bacteria diagnosis and how AI tools detect it

AI Techniques Used in Bacterial Struture Detection 
Machine Learning 

a. K-nearest neighbors (k-NN).
b. Support Vector Machines (SVMs).
c. Random Forests (RF) and eXtreme Gradient 

Boosting (XGBoost).
d. Gradient Boosting (XGBoost, LightGBM,CatBoost)

Deep Learning
1. Convolutional Neural Network (CNNs). 
2. Long Short –Term Memory (LSTM)
3. Transformers

Other AI Tools
1. Neural network –based sensors

2. Object detection algorithms (R-CNN, YOLO v5)
3. mGPS AI tool.

Machine Learning 
K-nearest Neighbors (k-NN)
It helps in classifying the new set of  information  based on 
their proximity to calculated data points. Generally, k-NN 
compares a new data points with the near by neighbors in 
the information set. It is knoweldgeable in identifiying the 
different speices of  bacteria and classifying the bacterial 
structure on their properties. 

Support Vector Machines (SVMs)
This learning algorithms classify data of  bacteria on their 
features like genome sequences, shape, size, protein or 



Pa
ge

 
56

https://journals.e-palli.com/home/index.php/ajmsi

Am. J. Med. Sci. Innov. 4(2) 53-72, 2025

lipid structure and metabolic pathways. SVMs identify 
the antimicrobial resistance in bacteria. It work by 
categorizing  the data points in a hyperplane.

Random Forests (RF) and eXtreme Gradient 
Boosting (XGBoost)
It analyze the data by images that is TEM microscopy, 
gene pool information of  bacteria. Apart from this, 
it can identify and classify the bacterial infection more 
accurately, efficiency,robustness by combining with the 
CNNs tool. Furthermore, it is also used in assisting the 
antibiotics susceptibility and indentifying antimicrobial 
peptides. It can handle the complex data record. 

Gradient Boosting (XGBoost, LightGBM, CatBoost)
Currently,this AI arithmetic gaining the importance in 
identying the bacterial structure. It has a power to tackle 
with the more complex data file. It usually helpful in 
predicting the cytometric data (measures the physical 
and chemical characteristics of  cells) techniques – flow 
cytometric, classify the bacteria on their methabolic 
phases and  superbugs (antimicrobial resistance).  

Deep Learning
Convolutional Neural Network (CNNs)
It is based on the images information and automatically 
colonies of  bacteria can be find. CNNs used to identify 
potential new drug of  antimicrobial resistance. Apart 
from this, it also has power in maintaining the quality 
control processes and ensure the drug purity, safety and 
efficiency. 

Long Short –Term Memory (LSTM)
It is the advance or improved version of  the 
Recurrent Neural Network  (RNN), helps in language 
translation,recognition of  words and forecasting the 
sequenc of  data points that are ordered by time. Time 
sequence of  data is oftenly plotted graphically, time on 
x- axis and variable’s value on the y-axis. 

Transformers
It is valuable tool in detecting the bacterial infection, 
mainly vision transformers are used. It detect by analyzing 
the images of  gram –stained smears and chest X-rays. 
Transformers with the help of  clinical data of  the patient  
can determine the bacterial infection.

Other AI Tools
Neural Network –Based Sensors
CNNs artificial intelligence tool is a neural network sensor 
which is capable of  diagnostic the bacterial infection. it is 
more prominent in speeding up identification processes. 

Object Detection Algorithms (R-CNN, YOLOv5)
This is based upon the image information with the 
help of  deep learning (DL) bacterial images can 
obtained and examine in detail that is it provide the 
bacterial structural information as well as diagnosing 

and identifying  the bacterial infection caused by which 
type of  microorganisms and treating infectious diseases  
caused by pathogenic bacteria. YOLOv5, a powerful 
object detection method in assisting  the bacteria by 
counting colonies on agar plates. Mostly YOLOv5 is used 
in identifying the bacterial diseases in rice and bell papers 
(by bacterial colonies on agar plates).

mGPS AI Tool
It stands for Microbiome Geographic Population 
structure. This tool helpful in understanding the climatic 
conditions  in which bacteria is surviving or the origin of  
bacteria causing an infection. By using mGPS searchers 
or doctors can predict the bacteria environment in 
which it grows even from where the bacteria is carried 
by individuals (like city center, beach etc). It also aid the  
microbial communities. 

LITERATURE REVIEW
Today, AI is considered a branch of  technology and 
engineering that develop novel concepts and novel 
solutions to resolve complex challenges. With the 
passage of  time, AI continued progress in electronic 
speed, capacity, and software programming that 
might create computers intelligent as human beings. 
Cheng and Druzdzel (2000) develop an algorithm for 
evidential reasoning in large Bayesian networks. An 
adaptive importance sampling algorithm, AISBN that 
shows promising convergence rates even under extreme 
conditions is developed. It seems to outperform the 
existing sampling algorithm consistently. This provides 
a better substitute to stochastic sampling algorithms 
that have been observed to perform poorly in evidential 
reasoning with extremely unlikely evidence. Grunwald 
(2001) and Halpern (1989) focused on the theoretical 
foundations of  probability updating and predictions 
under uncertainty. Aim to refine the AI system to give 
better decisions in the case of  uncertainty and work on 
the safe probability and ignore certain information that 
leads to have accurate predictions, particularly when 
handling with the irrelevant data
The potential of  artificial intelligence (AI) to augment 
and partially automate research in many scientific 
disciplines, including the health sciences (Adams et al., 
2013; Tsafnat et al., 2014), biology (King et al., 2009), 
and management (Johnson et al., 2019). In particular, 
the concept of  automated science is raising intriguing 
questions related to the future of  research in disciplines 
that require “high-level abstract thinking, intricate 
knowledge of  methodologies and epistemology, and 
persuasive writing capabilities” (Johnson et al., 2019: 292). 
These debates resonate with scholars in Information 
Systems (IS), who ponder which role AI and automation 
can play in theory development (Tremblay et al., 2018) 
and in combining data-driven and theory-driven research 
(Maass et al., 2018). With this commentary, we join the 
discussion which has been resumed recently by Johnson 
et al. (2019) in the business disciplines. The authors 



Pa
ge

 
57

https://journals.e-palli.com/home/index.php/ajmsi

Am. J. Med. Sci. Innov. 4(2) 53-72, 2025

observe that across this multi-disciplinary discourse, two 
dominant narratives have emerged. The first narrative 
adopts a provocative and visionary perspective to present 
its audience with a choice between accepting or rejecting 
future research practices in which AI plays a dominant 
role. The second narrative acknowledges that a gradual 
adoption of  AI-based research tools has already begun 
and aims at engaging its readers in a constructive debate 
on how to leverage AI-based tools for the benefit of  
the research field and its stakeholders. In this paper, 
our position resonates more with the latter perspective, 
which is focused on the mid-term instead of  the long-
term, and well-positioned to advance the discourse with 
less speculative and more actionable discussions of  
the specific research processes that are more amenable 
applications of  AI and those processes that rely more on 
the human ingenuity of  researchers. Mintz and Brodie., 
2019  AI has begun to incorporated into medicine to 
improve the pateints compliance by speeding up processes 
as AI tools like DL helps in achieving the accuracy and 
opening the way to provide better healthcare. Their 
search has revelated that with the  help of  radiological 
images, pathology slides and patient’s electronic medical 
records (EMR) evaluated by machine learning helps in 
the diagnosis process, treatment of  patients and  to add 
other treatment to improve outcomes of  patients.
AI’s transformative potential in business and management 
has garnered significant research attention (Laurim et 
al., 2021; Østerlund et al., 2021). As businesses seek to 
leverage AI for competitive advantage and navigate 
complexities, literature reviews have become essential 
in providing insights. AI literature reviews often take a 
narrow approach, focusing on specific problems within 
particular research domains. While these literature reviews 
have contributed
valuable insights into their respective fields, they often 
focus on specific application areas. For example, within 
information systems, literature reviews have focused 
on topics such as AI in fitness recommender systems 
(Venkatachalam & Ray, 2022) and the impact of  AI 
on public governance (Zuiderwijk et al., 2021), while 
in marketing, reviews have analyzed AI in customer 
relationship management (Ledro et al., 2022) and 
consumer-machine relationships (Pentina et al., 2023). 
Reviews often look at the intersection of  these areas, such 
as Kaufmann et al. (2023), who review the role of  tasks in 
the acceptance of  AI and algorithm advice.
The traditional approach to diagnosing bacterial infectious 
diseases, laboratory technicians rely on microbiological 
and biochemical tests to identify pathogens. It includes 
bacterial culture, morphological observation, biochemical 
reaction tests, and serological techniques (Ernst et al., 
2006; Váradi et al., 2017). In addition, molecular biology 
techniques are widely used for the identification of  
bacterial DNA sequences, of  which the polymerase 
chain reaction (PCR) is a commonly used method 
(Wilson, 2015; Deusenbery et al., 2021). Although PCR 
technology is more advanced than traditional biochemical 

and microbiological methods, it requires a long time 
to complete the experimental process. Moreover, the 
integration and application of  AI technology not 
only optimizes the traditional bacterial detection and 
management process, but also has the potential to bring 
about a complete revolution (Ho et al., 2019; Wang et al., 
2020; Paquin et al., 2022; Howard et al., 2024)
Future of  AI can be imagined in terms of  its capabilities 
and opportunities, it must be recognized that AI can 
also present a number of  challenges and ongoing issues 
due to the complexity of  the integration of  healthcare 
environments with a purely machine learning-supported 
AI intervention. Some of  the main risks and challenges 
that have emerged are patient injury from system errors 
(Aljaaf  et al., 2015; Srivastava & Rossi, 2019; Madanan et 
al., 2021; Dwivedi et al., 2021), patient privacy concerns 
limiting data access, and the ethical, legal and medical 
challenges of  making decisions about human lives and 
medical conditions using AI (Liu et al., 2020; Shaban-
Nejad et al., 2021). Goodswen et al. (2021) explored the 
use of  AI in medical microbiology and related field. 
Apart from this, its work is mentioned inrelation to AI 
in diagnosing and treating the bactrial infections.With 
the aid of  machine learning (ML) microbial interactions 
can be understand accurately and used in metagenomics 
to predict microbial functions and analyze data. Moving 
further, they proved that AI is also playing cruical role in 
accerelating the vaccine development by understanding 
the pathogen infection cycles and identifying the active 
antigens which cure the infection. In supervised learning, 
algorithms train pre-cataloged data thus enabling for the 
predictions for new unseen data by drawing the pattern 
with known outcomes and encompassing classification 
and identifying the genetic markers associated with traits 
like virulence and antimicrobial resistance. The use of  AI 
that is with X-rays and CT scans physicians can diagnose 
and treat the bacterial infections esaily as compared to the 
traditional methods. AI used to enhance the speed and 
accuracy of  pathogen detection and resistance prediction 
(Jiang et al., 2022). AI tools were used to track the 
evolution and transmission patterns of  infectious diseases 
thus, enabling public  better health outcomes. Bellini et 
al. (2022) work in the realm of  medical microbiology, 
supervised machine learning models on labeled datasets 
predict specific outcomes such as classifying microbial 
infections and predicting drug sensitivity. This approach 
results in diagnosis and treatment selection based on 
known patterns.on the other hand, unsupervised machine 
learning, analyze unlabeled data, identifying inherent 
structures and grouping similar data points. Unsupervised 
machine learning finds applications in group analysis, 
identification of  microbial subtypes and early recognition 
of  infectious threats. Often in the hybrid both methods 
are employed, leveraging the strengths for diagnosing 
the infection accurately and insight into microbial  
interactions.Unsupervised learning, employing clustering 
methods such as k-means and hierarchical clustering for 
characterizing complex ecological dynamics. 



Pa
ge

 
58

https://journals.e-palli.com/home/index.php/ajmsi

Am. J. Med. Sci. Innov. 4(2) 53-72, 2025

Regardless of  the AI challenges, one of  the most 
important benefits of  AI is its support in preventative 
care in the healthcare system that promotes all humans 
to become and remain healthy. For example, apps have 
been used to give patients more control over their health 
(Antoniou et al., 2018; Jaiman & Urovi, 2020; Samuel et al., 
2022), allowing them to make evidence-based decisions 
on the matters of  preventative health issues, such as type 2 
diabetes and high blood pressure. However, early detection 
and diagnostics of  health information require many AI 
apps (Stamford et al., 2016; Siddiqui et al., 2018; Kumar 
& Suresh, 2019). These AI apps are used in a variety of  
settings to diagnose different types of  illnesses for precise, 
rapid and reliable results (Ribbens et al., 2019; Sasubilli et 
al., 2020; Jahan & Tripathi, 2021). At the simplest level, AI 
performs a significant level of  comparative analysis using 
Big Data so that information from a patient is compared 
with data and digital images from huge datasets compiled 
from other patients in relevant and related settings 
(Charan et al., 2018; Somasundaram et al., 2020). This 
type of  self-learning mechanism recognizes patterns and 
provides information for medical practitioners to support 
their diagnosis and intervention strategies (Charan et al., 
2018; Woo et al., 2021). While supporting these complex 
medical procedures, AI technologies can also improve 
the efficiency of  medical care administration (Deng et al., 
2019; Daltayanni et al., 2012).
AI-powered diagnostic tools can enhance bacterial 
detection by using low-cost smart gadgets based 
images process, cloud-based diagnostic platforms and 
computerized electronic clarifications which helps 
to diagnosis the clear images of  bacterial infection 
microorganisms and their shape. It gives better results 
and counter plot the disease ratio Min et al., 2021; Yu et 
al., 2023.
Lee et al. (2024) Artificial intelligence (AI) integration 
help in the bacterial infection diagnostics and AST offers 
an effective solution to many challenges. Lee research has 
shown that AI has remarkable potential in automating 
data analysis, improving diagnostic precision (Lee), 
and accelerating time to results. AI algorithms, such as 
machine learning (ML) and deep learning (DL) models, 
can easily analyze  and modify the complex datasets with 
high throughput, enabling faster, more accurate bacterial 
identification and susceptibility profiling. 

MATERIALS AND METHODOLOY 
Bacterial infection can be diagnosised by following 
methods:-

1  Clinical evaluation
2. Microscopy
3. Culture techniques
4. Biochemical tests
5. Serological assays 
6. Molecular methods

These techniques assist in detecting the existence of  
bacteria, identifying the particular type of  bacteria, and 
evaluating its sensitivity to antibiotics.

Clinical Evaluation and Sample Collection
Healthcare professionals evaluate symptoms, conduct 
physical examinations, and may request imaging studies 
(X-rays, ultrasound, MRI, CT scans) to identify signs of  
infection, especially in internal organs. Samples such as 
blood, urine, sputum, or swabs from infected regions are 
gathered for additional analysis. For example, in direct 
testing of  antigens in clinical samples has significantly 
contributed to the swift identification of  species. Urine 
antigen testing has been extensively utilized for detecting 
pathogens in respiratory infections caused by Legionella 
pneumophila and Streptococcus pneumoniae. Antigens 
released by these pathogens and excreted through 
the urinary tract are typically identified using enzyme 
immunoassay (EIA) or lateral flow assay (LFA). Although 
antigen testing offers a reduced turnaround time (TAT), 
it is hindered by low sensitivity and specificity, particularly 
in children colonized with S. pneumoniae, and it cannot 
provide profiles of  antibiotic susceptibility or other 
epidemiological information. The rapid detection 
of  antigens from various clinical samples, such as 
blood, throat swabs, synovial fluid, pleural fluid, and 
cerebrospinal fluid (CSF), has been previously investigated 
but is not widely implemented in clinical practice. A 
significant retrospective multicenter study evaluated the 
clinical effectiveness of  rapid bacterial antigen detection 
through latex agglutination and found them to be 
expensive with no observable clinical advantage. Nucleic 
acid amplification testing (NAAT) or polymerase chain 
reaction (PCR) tests represent a dependable non-culture 
method for microbial detection, commonly employed in 
laboratories worldwide for diagnosing a diverse range of  
microbial pathogens. Moreover, multiplex PCR integrates 
multiple primers and probes within a single reaction 
tube to amplify gene targets from various pathogens. 
This highly sensitive technique enhances diagnostic 
yield and can be applied to numerous clinical specimens, 
including respiratory secretions, CSF, sterile fluids, and 
diarrheal feces. However, the limitations of  PCR testing 
include the reporting of  incidental findings, an inability 
to differentiate between colonization and infection, 
the necessity for skilled operators and a specialized 
laboratory setting, and the lack of  antibiotic susceptibility 
data. Additionally, PCR will only identify pathogens that 
are specifically targeted by the assay design, potentially 
missing rare and unexpected organisms or strains with 
variations.

Microscopy
The direct examination of  samples under a microscope, 
possibly utilizing staining methods like Gram stain, can 
disclose the presence and morphology of  bacteria. This 
technique aids in the preliminary identification based on 
characteristics such as shape, size, and staining properties.

Bright-Field Microscopy
This is the most prevalent form of  microscopy utilized, 
frequently alongside with Gram staining. 



Pa
ge

 
59

https://journals.e-palli.com/home/index.php/ajmsi

Am. J. Med. Sci. Innov. 4(2) 53-72, 2025

Gram Staining
This technique categorizes bacteria into Gram-positive 
and Gram-negative groups based on their cell wall 
composition, offering insights into the bacterial identity. 

Other Staining Techniques
Depending on the suspected infection, alternative stains 
such as acid-fast stains (for mycobacteria) or capsule 
stains (for detecting capsules) may be utilized. 

Wet Mount Microscopy
This technique involves the examination of  a sample 
within a liquid medium, commonly used for detecting 
bacteria in bodily fluids like cerebrospinal fluid or for 
identifying bacteria in vaginal or wound swabs. 

Fluorescence Microscopy
This method employs fluorescent dyes that attach to 
specific bacterial components, facilitating highly specific 
and sensitive detection of  bacteria. 

Culture Techniques
Samples are cultivated on various media to promote 
bacterial growth. Selective media are employed to isolate 
particular types of  bacteria. The growth characteristics, 
colony morphology, and biochemical reactions of  the 
isolated bacteria are subsequently examined. 

Biochemical Tests
These assessments evaluate the metabolic characteristics 
of  bacteria, including their capacity to utilize specific 

sugars or produce certain enzymes. An example is the 
coagulase test for Staphylococcus aureus. 
A coagulase test is a biochemical assay utilized to 
distinguish Staphylococcus aureus from other species of  
Staphylococci, such as S. epidermidis and S. saprophyticus, 
based on their capacity to produce the coagulase enzyme.
Coagulase can be identified using two distinct methods: 
the tube test and the slide test. 

Slide Test 
1. Approximately 10 µl of  deionized water or 

physiological saline is placed on a slide. 
2. Several colonies from a fresh culture are gathered 

with an inoculating loop and emulsified into the water to 
create a smooth, milk-colored suspension. 

3. A drop of  rabbit or human plasma is then added to 
the slide, and clumping is observed immediately, ensuring 
it does not exceed 10 seconds. 

Tube Test 
1. The plasma is diluted with physiological saline (0.2 

ml of  plasma is added to 1.8 ml of  saline). 
2.  5 ml of  the diluted plasma is subsequently transferred 

to a test tube, followed by the addition of  approximately 
5 drops of  the test organism culture. 

3. The contents of  the test tube are mixed and 
incubated at 37°C for one hour. 

4. Finally, the tube is examined for clot formation. If  
no clotting is detected, the tube should be checked at 
30-minute intervals for up to 6 hours.

Figure 4: represents the result of  different coagulase test appearance

Serological Identification
Serological assessments identify bacterial antigens or 
antibodies in patient samples. Elevated or increasing 
titers of  specific IgG antibodies or the detection of  IgM 
antibodies may indicate or confirm a diagnosis.

Working of  Serological Tests
A blood sample is collected, and the serum, which is the 

liquid component of  the blood, is isolated. 
The serum is subsequently analyzed for the presence and 
quantity of  specific antibodies through various methods 
such as: 

ELISA (Enzyme-Linked Immunosorbent Assay)
A widely used technique that employs antibodies to 
identify antigens or the reverse. 



Pa
ge

 
60

https://journals.e-palli.com/home/index.php/ajmsi

Am. J. Med. Sci. Innov. 4(2) 53-72, 2025

Agglutination Tests
Identify antibodies that induce the clumping of  cells or 
particles. 

Complement fixation tests
Identify antibodies by assessing the consumption of  
complement proteins. 

Immunofluorescence Assays
Utilize fluorescently labeled antibodies to identify 
antigens or other antibodies. 
The outcomes of  these tests can reveal whether an 
individual has been exposed to a specific pathogen or if  
their immune system is reacting to a vaccine.

Molecular Methods
Molecular techniques such as PCR (Polymerase Chain 
Reaction) amplify specific bacterial DNA or RNA 
sequences for identification. These methods are highly 
sensitive and specific, capable of  detecting even non-
culturable bacteria. MALDI-TOF MS (Matrix-Assisted 
Laser Desorption Ionization-Time of  Flight Mass 
Spectrometry) is another molecular technique utilized 
for rapid bacterial identification through the analysis of  
protein profiles.

Antimicrobial Susceptibility Testing (AST)
AST evaluates the efficacy of  various antibiotics against 
the identified bacteria. This information assists in 
determining the appropriate antibiotic treatment.

Other Techniques
Immunofluorescence and immuno-peroxidase staining 
can identify specific microorganisms. Both techniques 
employ antibodies to attach to specific antigens; however, 
they vary in their visualization of  the antibody-antigen 
complex. Immunofluorescence (IF) utilizes fluorescent 
dyes  (fluorophores) linked to antibodies, whereas 
immunoprecipitation (IP) employs enzymes (such as 
horseradish peroxidase) that facilitate a reaction resulting 
in a colored precipitate.

Techniques
Immunofluorescence 

Mechanism
A fluorescent dye (fluorophore) is either directly or 
indirectly linked to the antibody that attaches to the target 
antigen. 

Visualization
The tissue is analyzed using a fluorescence microscope, 
where the fluorophore emits light at a designated 
wavelength when stimulated by a light source. 

Advantages
1. High sensitivity. 
2. Allows for the detection of  multiple targets at once 

(multicolor IF).
3. Can be conducted on either frozen or fixed tissue. 

Disadvantages
1. Requires a specialized fluorescence microscope. 
2. Fluorescence may diminish, complicating the long-

term storage of  slides. 
3. May exhibit lower specificity compared to IP in 

certain instances

Immuno-Peroxidase (IP)
Mechanism
An enzyme, typically horseradish peroxidase, is linked 
to either the antibody or a secondary antibody. This 
enzyme facilitates a reaction with a substrate, resulting in 
a colored precipitate at the location of  antigen-antibody 
interaction. 

Visualization
The tissue is analyzed using a standard light microscope.

Advantages
1. It is more durable and less susceptible to fading 

compared to Immunofluorescence (IF).
2.  It enables permanent staining and the ability to 

archive slides. 
3. It can be applied to fixed and paraffin-embedded 

tissues. In certain instances, it may exhibit greater 
specificity.

Disadvantages
1. It may demonstrate lower sensitivity than 

Immunofluorescence. 
2. The process can be more time-intensive. 
3. There is a risk of  background staining due to the 

activity of  endogenous peroxidase.
AI methods can be broadly classified into three main 
types namely :-

1. Symbolic AI
2. Machine learning
3. Evolutionary computation

Symbolic AI
It is also called as classical artificial intelligence or logic-
based artificial intelligence. It is define as the a subfield 
of  AI that focuses on  logic–programming that is on the 
symbols and logical reasoning to solve problems rather 
than numerical data. It involves the certain rules and 
knowledge to perform the tasks like logical reasoning, 
problem-solving and language understanding. It developed 
applications such as knowledge-based system,symbolic 
mathematics, theorem proofs, automated planning and 
scheduling system. Researchers in the 1960s snd the 
1970s eventually stated that Symbolic AI with machine 
learning successly predict the logic theorist and Samuel’s 
checkers playing program. This approach is highly 
interpretable, as it can easily trace the reasoning process 
to the logical rules applied. It allows the system’s rule to 



Pa
ge

 
61

https://journals.e-palli.com/home/index.php/ajmsi

Am. J. Med. Sci. Innov. 4(2) 53-72, 2025

modify or manipulate the ideas or a new information. It 
is very useful techique as compared to machine learning 
– it doesnot require the vast numerical data, it is based 
on knowledge, representation and reasoning. Symbolic 
AI depends on the problem domain and data availability 
whereas machine learning requires large data records 
to learn and draw the pattern and make predictions. 
Apart from this, it can help in the hybrid systems that is 
combining symbolic AI with other AI tools like neural 
networks to increase their strength. 

Key points of  Symbolic AI
Knowledge Representation:- Symbolic AI  has ability to 
represent the knowledge as reasonable statement, rules 
and symbolic representations. 

Symbolic Reasoning 
In this context, symbols and rules are manipulated to 
draw inferences and derive results.

Logical Inference
With the aid of  symbolic AI, researchers can perform the 
tasks related to logic–based reasoning such as,problems 
solving and predicting  upcoming challenges.

Rules- Based Systems
In rule-based systems, human made rules to sort, store, 
modify and manipulate the data. It describes how the 
system will work in the particular situations by following 
the different sets of  rules.

values or converting data formats. 

Feature Engineering
Identifying and selecting relevant features from the data 
that can be used as input for the model is crucial. This 
process can involve creating new features or transforming 
existing ones to improve the model’s performance. 

Model Selection and Training
Choosing the appropriate machine learning algorithm 
(e.g., supervised, unsupervised, or reinforcement learning) 
and training it on the prepared data is a key step. This 
involves adjusting the model’s parameters and evaluating 
its performance. 

Model Evaluation and Validation
After training, the model’s performance needs to be 
evaluated using metrics and techniques like cross-
validation to assess its accuracy and generalization ability. 

Deployment and Monitoring
Once the model is validated, it can be deployed to 
make predictions or decisions in real-world scenarios. 
Continuous monitoring of  the model’s performance and 
retraining it with new data is often necessary. 

Types of  Machine Learning Algorithms
There are four types of  ML

Supervised Learning
This type of  ML uses labeled data to design models that 
can make predictions or classifications. It can handle the 
regression problems where input and output variables 
have a linear relationship. For example in weather 
prediction, market trend analysis etc. 

Unsupervised Learning
It analyzes unlabeled dataset and discover patterns and 
structures    without any supervision, such as clustering or 
dimensionality reduction. It is also help to identify typical 
relations between the large dataset variables. It can be 
used in the market data analysis.  

Reinforcement Learning
It is feedback based process. It automatically takes the 
information from hit and trial method and solves the 
problems. It takes action, learns from the experiences and 
improves performance. It aims to maximize the rewards 
by doing good tasks and improved productivity. 

Semi-supervised Learning
It is the combination of  both supervised and unsupervised   
machine learning. It helpful in labeled and unlabeled data 
for training but more useful when labeled data is limited. 

Evolutionary Computation
It is the collectively the efforts of  nature-inspired AI 
algorithms as well as computer science that optimizes the 

Machine Learning (ML)
It is a subfield of  AI that focus on data or past experiences 
enabling the computer to slove the problems without the 
human interruption. It depends on algorithms to inform 
what actions are taken and what outcomes come or 
decisions.

Data Collection and Preparation
Machine learning algorithms require data to learn    from. 
This involves gathering, cleaning, and organizing data, 
often including preprocessing steps like handling missing 



Pa
ge

 
62

https://journals.e-palli.com/home/index.php/ajmsi

Am. J. Med. Sci. Innov. 4(2) 53-72, 2025

biological evolution. It can provide the best solutions for 
a variety of  prooblems like genetic mutation, hereditary 
problem. Evolutionary Processes that mimic biological 
evolution includes inheritance,mutation and natural 
selection. 
Working of  EC:

1. Initialization: The primary step is randomly 
population of  potential solutions is created.

2. Evaluation: According to the fitness parameter each 
solution is evaluated that measures its performance.

3. Selection: The best solutions are selected to 
reproduce and contribute to the next generation.

4. Recombination:  Selected solutions are combined to 
create new offspring.

5. Mutation: Random changes are introduced to the 
new offspring.

6. Iteration: The process is repeated, with each 
generation refining the solutions until a satisfactory 
solution is found. 

Benefits of  EC 
1. By using EC, one can handle the complex problems 

and variables to solve the relationships that are difficult 
for traditional algorithms to solve. 

2. Robustness: EC algorithms are often robust to noise 
and variations in the problem space. 

3. EC can be used in various fields, including 
engineering, finance, and bioinformatics. 

Examples of  EC Applications
1. It finds the best solution to a problem, such as 

minimizing costs or maximizing performance.
2. With the help of  machine learning, designing and 

optimizing machine learning models can be made. 
3. It helps in developing algorithms for robot navigation 

and control.
4. It can design new molecules for drug development

Others
Distributed Ledger Technology (DLT)
DLT integrated with AI describes a novel and advanced 
method to achieve the intelligent, resilient, and safe 
handling of  electronic health record data. DLT is an 
innovative and rapidly growing method for recording 
and sharing data across different data stores (ledgers). It 
is secure, immutable, and readily available. It can allow 
patients to take control of  their own data, eventually 
generating trust in an industry that matters to all of  us.

Metaverse
It a virtual universe that is mirror the physical world 
with the social, economies and ecosystems interactions. 
It is giving a new shape of  digital existence, where the 
boundaries between the real and virtual worlds blur. AI 
role in the metaverse is complex. AI algorithms simulate 
the respond between user and creation (environment) 
which in return provide opportunities for personalized 
treatment. Additionally, AI is acting as the catalyst for 

driving new techniques enhancing user experience.  
Surgeons can use the metaverse and AI to do surgeries 
which are complicated or can practice the surgery before 
doing on the patients.  

Application of  AI In the Diagnosis of  Bacterial Infection
Identification of  Pathogen with AI
AI can algorithms can analyze various data sets by 
performing mass spectrometry, microscopy images and 
images capture by normal mobile, easily to identify the 
bacteria type.

AI Enhances Accuracy
With the help of  AI powered tools we can achieve the 
accurate result in indentifying the different bacterial genes, 
including their subtypes and antibiotic resistant strains. 
For examples: - AI can predict more complex techniques 
like Raman and SERS very clearly. Two Staphylococcus 
aureus subspecies can identify very uniquely with the AI 
algorithms- MALDI-TOF MS correctly. Furthermore, 
AI used to study autoinducer-2 (AI-2) in S. aureus, giving 
the path to know the attachment of  molecules involved 
in between the species board casting and influencing 
anaerobic-bacteria formation. Aureus NCTC8235 and 
AI-2 together can regulate the gene expression.

AI Role In Pandemic And Epidemic Surveillance of  
Bacterial Infectious Diseases
Artificial intelligence (AI), or machine learning, is an 
ancient concept based on data analytics. AI techniques 
are useful in the computational methods to survey the 
record file, single out patterns, pick out the high risk 
population and grasping disease mechanisms. 
 During the COVID-19 pandemic, AI tools were used in 
genome sequencing, development of  drug and vaccine, 
identifying disease and his causative organism, monitoring 
disease spread, and tracking viral variants. AI-driven 
approaches complement human-curated ones, including 
traditional public health surveillance. The hybrid models 
of  AI that is ML (machine learning and DL (Deep 
Learning) are used in the detection of  disease cause. Apart 
from it, Infectious disease dynamics (IDD) and dynamic 
Bayesian networks (DBN) models helps in finding the 
spread of  disease and its accuracy  helps in knowing the 
strength of  the spread of  disease. All these specialized 
tools help in the epidemiology superintendence of  the 
disease, data analysis and interpretation. For example, 
machine learning models can predict in advance the risk 
of  Clostridioides difficile infection among patients in 
large hospitals, allowing healthcare teams to implement 
preventive measures proactively before infection occurs 
(Oh et al., 2018; Tilton & Johnson, 2019).

Clinical Applications of  AI In Identification And 
Management of  Bacterial Infection 
AI tools in clinical testing have abundant uses in diagnosis, 
management of  disease and optimizing the health hazards 
of  the patients. It can analyze by X-rays, MRIs and CT 



Pa
ge

 
63

https://journals.e-palli.com/home/index.php/ajmsi

Am. J. Med. Sci. Innov. 4(2) 53-72, 2025

scans. AI in radiology, images help in analyzing the disease 
which reduces the interpretation time. Furthermore, in 
cardiology AI features help in diagnosing the cardiac 

activities that is with the help of  ECG report it’s very 
simple to predict the heart attracts chances.

Figure 6: Following are the key applications of  AI in the clinical practice

For example in case of  pneumonia, the alveoli, small 
sacs within the lungs, are filled with pus and fluid, which 
makes breathing painful and limits oxygen exchange.
There are more than 30 different causes of  pneumonia, 
and they are grouped accordingly: bacterial pneumonia, 
viral pneumonia, mycoplasma pneumonia and other 
pneumonias. AI tool artificial neural networks (ANNs) 
based on deep learning shown a promising response in 
diagnosing the pneumonia causative organism accurately 
and treatment for particular bacterial infection caused by 
which type of  pneumonia.

AI Act As Paradigm Shift In Drug Discovery And 
Development
For treating the bacterial infection one of  the difficult 
challenges are resistant to antimicrobial agents and diverse 
of  bacteria. In 2019, globally, it has reported that above 
4 million people died due to resistance of  antimicrobial. 
Bacteria have acquired the resistance to the antimicrobial 
drugs as microbes adapted to the environment, genetic 
mutation which reduces the efficiency of  antimicrobial 
drugs. Additionally, diversity of  bacteria and interaction of  
bacteria and host creates complexity which results in the 
management or difficult for treatment. So, AI technologies 
simulates the complex interactions between pathogens, 
host and drug, thus helps in revealing the features of  
infections and optimizing the drug and vaccine designs.
AI tools are the boons to the searchers that have huge 
benefits in the drug and research development. It 
provides new strategies to overcome the problems of  
drug resistance. Models of  AI can help the developers in 
predicting the drug physicochemical properties identify 
promising drug candidates and provide best match to 
formulate and design the drug. For example, De Novo.

Drug Design
AI can generate novel molecular structures with specific 
biological properties, enabling the design of  drugs from 
scratch. Moving further, AI can identify the relationship 
between pathogen, target site, genotype and chemotype, 
providing the best come out way to breakout the 
antimicrobial resistance and provide therapeutic effective 
drugs. AI easily analyzes the molecular character and 
predicts the binding affinities of  the target ligands and 
which compound can work more potentially. For e.g.- 
tuberculosis (TB) and multi resistant infections, AI by the 
chest X-ray, coughs sounds and genomic analysis, drugs 
that develop the resistant with all these data information 
we can find the effective treatment for T.B patients. 
Current studies that revealed that AI tool especially 
machine learning (ML) helps in diagnosis, prediction, 
understanding the causes, treatment and management of  
disease. It can identify the failure of  antibiotics and its 
reason behind it. From that information, searchers can 
analyze and generate a new molecule of  drug and vaccine 
to cure T.B and multi-resistant infection.
Lastly, the application of  AI in predicting DR can aid 
in the personalized selection of  medications, avoiding 
unnecessary antibiotic use, and reducing the spread of  
DR strains. Improving patient treatment outcomes 
and quality of  life but also contribute to guiding future 
research and clinical practice, driving advancements in the 
field of  healthcare.

AI Can Predict And Analysis The Toxic And Side 
Effects of  The Drugs 
In the recent studies it has revealed that AI algorithms 
easily and quickly predict the toxic effect of  drugs by 
determining the large data record (from clinical trial data, 



Pa
ge

 
64

https://journals.e-palli.com/home/index.php/ajmsi

Am. J. Med. Sci. Innov. 4(2) 53-72, 2025

patient reports etc), identify the patterns and predict 
outcomes. By analyzing the pharmacokinetics data, 
safe dose amount can be calculated (dose regimen) and 
minimizing the side effects. For example the increase of  
antibiotic resistance, tigecycline a new broad-spectrum 
of  class synthetic tetracycline antibiotics (glycylcycline 
antibiotic) is widely used in the tissue infections, 
abdominal infections caused by pneumonia. It works by 
inhibiting bacterial protein synthesis, act as bactericidal. 
Apart from this, it can be evaluated by the ratio of  AUC0-
24 to the minimum inhibitory concentration (MIC) of  
pathogens. However, tigecycline may cause nausea, 
vomiting, diarrhea and a few patients have elevated 
serum aminotransferase, especially in critically ill patients. 
AI tools with the combination of  physiologically based 
pharmacokinetic (PBPK) predict the ADME parameters. 

AI Helps In Come The to An End Bleeding In 
The Upper Gastrointestinal Track Caused by 
Helicobacter Pylori Bacterial Infection
Helicobacter pylori are the bacteria which attacks the 
lining that protects the stomach. The bacteria make an 
enzyme called urease which neutralizes the acids in the 
stomach.  H. pylori also weaken stomach’s lining. Then 
the stomachs cells are at high risk of  explore or hurt by 
acid and pepsin, strong digestive fluids. That can lead to 
sores or ulcers in stomach or duodenum.
Gastrointestinal endoscopy information can assist 
AI tools particularly; machine learning can overcome 
the problem of  upper GIT bleeding by bolstering risk 
assessment, helps in decision making of  dose regimen and 
positively improving the results.AI tools and CAD has 
shown a potentially result outcomes to analyze increasing 
loads of  numerical and categorical data in short times. It 
is also notably with AI algorithms achieving regulatory 
approval for AI-assisted colorectal polyp detection 
(computer-aided detection [CADe]) and characterization 
(computer-aided diagnosis [CADx]) in colonoscopy.

AI Speeding Up Vaccine Development 
AI-enabled computational models help to simulate 
various molecular configurations of  the spike protein 
which help the developers to assess the configuration and 
provoke an effective immune response. 
 AI criteria in vaccine development as follows:-

Antigen Selection
AI can identify the most effective antigenic determinants 
(epitopes) on a pathogen, which are the parts of  the 
pathogen that the immune system recognizes and targets 
for attack. This helps researcher’s focus on the most 
promising vaccine candidates. 

Immunogenic Design
AI technology can optimize the need of  design of  vaccines 
to ensure they are safe and effective. This includes how 
the vaccine will interact with the immune system and the 
best way to deliver the vaccine to the body. 

Prediction of  Immune Response
AI can model the immune response to potential vaccines, 
allowing researchers to predict how well vaccine can work 
and what side effects, adverse effect can be occurred and 
how it can be overcome. 

Tailored Vaccine
With the help of  AI one can craft to fit the person 
needs accordingly. Researcher can continue discovery the 
vaccine as per the need of  individual genetic information 
or immune response and possible sparse Auto encoders 
(SAEs). 
For example, COVID-19 pandemic confirmed how 
quickly mRNA vaccines can be designed and produced 
against a novel pathogen. It is also being used in the 
development of  treatments for non-infectious diseases, 
such as cancer.

Ai Plays Major Role for Improved Diagnosis And 
Treatment of  Bacterial Infections
In 2023, study showed that Artificial intelligence plays 
progressively vital role in the healthcare, providing 
intensified diagnostic accuracy, custom treatment 
strategies and improved patient compliance. The use 
of  machine learning for cancer diagnosis and staging 
from molecular data has in fact been around since the 
early 2000’s, where machine learning approaches such as 
clustering, support vector machine and artificial neural 
networks were applied to microarray-based expression 
profiles for cancer classification and by analyzing the 
medical data, various information from the health 
sectors, patient medical history, genetic information all 
these help in better and improved diagnosis. For instance, 
AI has become a powerful tool in the tailored medication 
generally in cancer and infectious disease.  AI helps in 
improving the accuracy and reliability in screening the 
cancer disease and detection method that is minimally 
invasive techniques such as liquid biopsies for circulating 
tumor DNA (ctDNA) or cfDNA, blood test allow for 
early detection of  cancer, monitoring risk of  relapse 
over time and guiding treatment options. As an example, 
MSI status can be predicted from ctDNA in endometrial 
cancer patients in order to inform immunotherapy-
based treatment. Developed a machine learning based 
approach, Lung-CLiP (cancer likelihood in plasma), that 
predicts the likelihood of  ctDNA in blood drawn from 
lung cancer patients. So, the death rate can be decreased 
by earlier detection of  cancer with the AI models. Usually, 
at last stage of  the cancer patient gets to know. 

AI Assisted Diagnosis of  Bacterial Vaginosis (BV) 
and (Vulvovaginal candidiasis) VVC in Vagina
VVC is the yeast infection that affects women worldwide. 
It is characterized by overgrowth of  the yeast Candida 
albicans. Overgrowth often occurs when there is 
imbalance between the vaginal microbiome resulting 
in vaginal itching, burning sensation, unusual discharge 
and discomfort during intercourse time. Around the 



Pa
ge

 
65

https://journals.e-palli.com/home/index.php/ajmsi

Am. J. Med. Sci. Innov. 4(2) 53-72, 2025

world 75% of  women suffered from bacterial vaginosis 
(BV). This study aims to develop a novel method for 

BV detection by integrating surface-enhanced Raman 
scattering (SERS) with machine learning (ML) algorithms. 

Figure 7: Microscopic image of  overgrowth of  Vagina cells

Figure 8: represents microscopic images of  normal vagina and vagina affected by bacterial infection

In recent years, AI algorithms particularly, Convolutional 
Neural Network (CNN) models gained the importance 
in analyzing microscopic images to identify and classify 
the microorganisms, bacterial vaginosis (BV) and VVC 
(Vulvovaginal candidiasis) which help the doctors to treat 
the infection accurately and can even be used to predict 
the effectiveness of  different treatments and potential 
complications. AI-assisted tool like CombiANT used to 
quantify the antimicrobial synergy and for the treatment of  
infection caused by BV. A cascaded deep neural network 
model is used to diagnosis VVC, demonstrating superior 
characteristics exactly as compared to experts. Therefore, 

this model holds potential for clinical application to aid 
in the diagnosis of  VVC. The diagnosis of  VVC requires 
identifying yeast pseudohyphae, budding yeast, and yeast 
from microscope images, necessitating the use of  object 
detection CNN models. R-CNN series and YOLO series 
CNN models have achieved notable success in target 
detection tasks in recent years. Convolutional Neural 
Network (CNN) models have transcended human 
performance such as image’s visual elements and image 
of  object detection. But CNN models diagnosis the 
medical images very smoothly, quickly in less time.



Pa
ge

 
66

https://journals.e-palli.com/home/index.php/ajmsi

Am. J. Med. Sci. Innov. 4(2) 53-72, 2025

AI Helps in Microbial Diagnosis
 AI is being used in various ways to examine the growth 
of  microbial infections as traditional microbial diagnosis 
faces challenges through detection process-culturing and 
isolating microorganisms consume time, false positives, 
cross contamination and difficult for data surveillance. AI 
tool deep learning, a subset of  ML, relies on artificial neural 
networks (ANNs) which analyze complex datasets (shape 
and structure of  microbial images or genetic information 
of  pathogens) and all other relevant information 
to identify pathogens, predict antibiotic resistance. 
By convolutional neural networks (CNNs) in digital 
pathology, automated bacterial classification, and colony 
counting further underscores AI’s versatility. Moreover, 
AI improves antimicrobial susceptibility assessment and 
contributes to disease surveillance, outbreak forecasting, 
and real-time monitoring. Thus, AI tool show promising 
paradigm-shifting advancements in healthcare. Apart 
from this, by incorporating the data record into DL, it 
enhances the detection of  cancer metastases in lymph 
nodes, prostate cancer and scoring ki67 in breast cancer. 
DL accelerates the process of  analyzing data, resulting in 
fast mode result speed and precision.  
Recent progressions in AI, particularly ML methodologies, 
are explored to study SARS-CoV-2, malaria, and 
mycobacteria serve to demonstrate AI’s potential for quick 
and4 precise diagnosis. In the context of  the SARS-CoV-2 
pandemic, AI and CNNs has increasingly a spectrum of  
applications such as virus genome sequencing that helps 
in decision making algorithms, discovery of  new molecule 
of  drug and shot development. AI and CNNs integration 
into pathology laboratories can elevate the precision of  
identifying microorganisms present on cytological and 
histological slides that diagnosis the COVID-19 causative 
agent, severe acute respiratory syndrome corona virus 
2 (SARS-CoV-2) using the PCR testing (blood sample 
and serum of  the patient can also be taken for testing) 
that identify the atypical profiles indicative of  tainted, 
thus facilitating the rapid and accurate diagnosis while 
minimizing false evidence.  

AI in Assisting in Diagnosis of  Infectious Skin Disease 
As we know, the largest organ of  human body is the 
skin. It covers all the body surface area and composed 
of  epidermis, dermis and hypodermis layers. Skin act as 
a protective barrier for external factor such as bacteria, 
chemicals and temperature changes. Various micro-
organisms residence on the skin surface like bacteria 
(Staphylococcus, Corynebacterium) fungi (Malassezia) 
and viruses (Herpes simplex, shingles) that inhibit the 
colonization of  pathogens. Therefore, the rapid diagnosis 
of  skin lesions is utmost importance for treatment of  
infectious diseases. In dermatology, AI has shown great 
promise in diagnosing skin conditions by analyzing 
medical images. AI algorithms have been developed 
to evaluate images of  the skin to detect and classify 
conditions such as melanoma, psoriasis and acne. These 
algorithms can enhance the diagnostic capabilities of  
dermatologists by providing a second opinion or flagging 
potential issues that may not be immediately apparent to 
the human eye. The integration of  AI into dermatology 
not only improves diagnostic accuracy but also increases 
efficiency by reducing the time required to analyze images.
With the growth of  AI, it aid in the dermatology in 
predicting disease progression and developing new 
treatments. AI can help in the early detection of  skin 
cancer and other infectious diseases which lead to timely 
treatment and better outcomes. AI tool deep learning 
and Convolutional neural networks (CNNs) gaining the 
importance in diagnosis of  infection of  skin. It provide 
medical image recognition, interpretation combining with 
histopathology to identify specific cells in images and 
further it combine with image  to identify key features 
to diagnosis of  various diseases such as cardiovascular 
diseases, endocrine diseases and tumors (Hutchinson 
et al., 2023; Giorgini et al., 2024; Makimoto & Kohro, 
2024). CNNs can also assist individuals with the 
diagnosis of  monkeypox skin lesions. Monkeypox caused 
by monkeypox virus (MPXV) it is zoonotic disease, 
characterized by skin lesions that present on macules 
and papules and later entered into vesicles, pustules. So, 

Figure 9: Artificial intelligence –assisted diagnostic model



Pa
ge

 
67

https://journals.e-palli.com/home/index.php/ajmsi

Am. J. Med. Sci. Innov. 4(2) 53-72, 2025

CNNs helps to detect the MPXV lesions and find out 
the best treatment to be given to patient which must be 
patient compliance, personalized medication can also be 
planned by optimizing the patient data.
Overall, AI holds promising revolution in dermatology 
and improving patient care. Challenges remain but AI 
increasing the valuable tool in the fight against skin 
disease. Ongoing research and development in future 
will minimize the obstacles thus, AI models will more 
likely to cover the datasets complex and convert to easy 
integration.  

AI Revolution In Diagnosis And Management of  
Fungal Nail Infection
Nail infection is caused by fungal infection namely, 
onychomycosis.  It is difficult to diagnosis onychomycosis 
fungal nail infection as it’s similar to other nail conditions.  
The current methods to examine fungal infection of  
nails include microscopic examination with potassium 
hydroxide, fungal cultures and periodic acid- Schiff  
biopsy staining. Culture is considered a gold standard for 
fungal identification that helps to determine the viability 
and pathogen species, but often requires 4–6 weeks for 
results due to the slow-growing nature of  many fungi. 
Culture media may get contaminated by environmental 
factors but use of  antimicrobial solutions inhibits 
bacterial growth in culture media. All these techniques 
are time consuming, variable sensitivity, costly and based 
upon human reliability and interpretation. Inspite of  
these, Molecular techniques, such as PCR (Polymerase 
Chain Reaction) and MALDI-TOF MS (Matrix-
Assisted Laser Desorption–Ionisation–Time of  Flight 
Mass Spectrometry) are significantly helpful in fungal 
diagnosis due to their ability to swiftly detect fungi with 

high sensitivity, often within a few hours. Moving on, 
undecylenic acid is a fatty acid that helps in the preventing 
the fungus nail growth. 
Dermoscopy is a technique used to examine the skin and 
its adnexa in detail, with magnification up to 10 times. 
This enhances the identification of  features that are not 
visible to the naked eye, aiding in the identification of  
skin conditions. The procedure has emerged as a valuable 
tool in onychomycosis diagnosis, offering a non-invasive, 
rapid, and precise method for evaluating nail abnormalities. 
Onychoscopy reveals distinct characteristics that facilitate 
the pattern of  fungal nail destruction and differentiation 
from other nail disorders. These features include a jagged 
proximal margin, longitudinal striae with multicolor 
vertical streaks, and spiked patterns indicative of  fungal 
invasion.
Artificial intelligence has made advancements in medicine, 
utilizing the machine learning, deep learning and other 
AI technologies to analyze complex medical datasets, 
enhance diagnostic accuracy, tailored treatment plans and 
improve patient compliance. Mostly the AI studies show 
accurate results. Deep learning model particularly, CNNs 
used to detect and classify fungal infections from images. 
Even machine learning algorithms helps in predicting 
treatment outcomes and personalized treatment based 
upon individual patient characteristics. One of  the most 
significant challenges is obtaining a large number of  
robust data for the training dataset of  high quality and 
standards. These data is essential to assure that AI is used 
its potential and improves patient outcomes. In addition, 
patient consent, data privacy, bias etc medico-legal issues. 
By studying these issues can be resolve and ensure that AI 
is ethically and safely for use in the clinical practice. 

Figure 10: List of  Infectious Diseases

Challenges of  AI in the Medical Field
While the application of  artificial intelligence (AI) 
in treating bacterial infections shows great potential, 
realizing its full effectiveness necessitates overcoming 
considerable challenges. A primary barrier is the issue 

of  data, which includes both its volume and integrity. 
Privacy concerns and regulatory constraints often 
hinder the collection, standardization, and sharing of  
data related to bacterial infections. These limitations 
make it difficult to access large, diverse datasets that are 



Pa
ge

 
68

https://journals.e-palli.com/home/index.php/ajmsi

Am. J. Med. Sci. Innov. 4(2) 53-72, 2025

essential for developing robust AI models. Consequently, 
AI applications in healthcare environments become less 
effective and applicable in other contexts (Cath, 2018; 
Baowaly et al., 2019; Hummel & Braun, 2020). The 
inherent complexity of  bacterial diseases poses additional 
challenges. The swift mutation rates and diverse infection 
mechanisms of  bacterial pathogens make it difficult to 
predict bacterial behavior and accurately assess antibiotic 
sensitivity. AI models in this domain must integrate 
knowledge from various disciplines, such as microbiology, 
genetics, biochemistry, and computer science. Developing 
comprehensive models requires significant resources and 
expertise, posing a considerable challenge for researchers 
working within constraints.
The lack of  a thorough legal framework and standardized 
norms for AI applications in the healthcare sector 
presents a considerable challenge. As AI technology 
progresses, it is essential to develop and regularly 
update laws to ensure its ethical, safe, and effective 
use in treating bacterial diseases. The establishment of  
clear guidelines and oversight will be vital in addressing 
issues related to accountability, bias, and the equitable 
implementation of  AI systems in clinical settings (Rees 
& Müller, 2022). Tackling these challenges requires 
interdisciplinary cooperation, the creation of  strict 
data sharing regulations, the adoption of  transparent 
AI models, and the development of  comprehensive 
regulatory frameworks. By overcoming these obstacles, 
AI has the potential to significantly enhance the detection 
and treatment of  bacterial infections, paving the way for 
innovative and personalized healthcare solutions.

RESULTS AND DISCUSSIONS
Artificial Intelligence is transforming the diagnosis, 
treatment, and prevention of  bacterial infections by 
facilitating quicker and more precise identification of  
pathogens, enhancing antimicrobial susceptibility testing, 
and advancing genomic analysis. AI-driven tools are also 
contributing to the early detection of  outbreaks, the 
formulation of  personalized treatment strategies, and 
the creation of  novel drugs and vaccines. Nevertheless, 
challenges persist regarding data quality, model 
interpretability, and ethical issues, including data privacy

Enhanced Diagnosis and Identification 
Quicker and More Precise Identification 
AI algorithms, especially those employing machine 
learning and deep learning techniques, are capable of  
examining intricate datasets from diverse sources (such as 
MALDI-TOF MS and genome sequencing) to swiftly and 
accurately identify pathogens.

Illustration
A research study integrated MALDI-TOF MS with 
ClinProTools software for the prompt identification of  
Staphylococcus aureus subspecies, achieving a remarkable 
100% accuracy through genetic analysis and an efficient 
classifier model. 

AI-Driven Image Analysis
AI technology can scrutinize medical images (including 
X-rays and CT scans) to identify indications of  infection, 
facilitating early diagnosis and the isolation of  infected 
individuals, which is particularly crucial during pandemic 
scenarios. Transfer learning and convolutional neural 
networks (CNNs) utilized for CX-R and CT imaging 
have demonstrated significant accuracy in identifying 
COVID-19.

Tackling Issues In Low-Resource Environments 
Artificial Intelligence (AI) can facilitate affordable, 
smartphone-based image analysis and cloud-based 
diagnostic solutions for bacterial identification in areas 
with limited resources. 

Improved Antimicrobial Susceptibility Testing (AST)
Enhancing Treatment
AI has the capability to evaluate bacterial genomes and 
susceptibility information to forecast antibiotic resistance 
and assist in choosing the most effective treatment 
options.

Illustration
AI-driven decision support systems can suggest the best 
antibiotic therapies based on patient information and 
local resistance trends.

Accelerating Drug Discovery
AI has the capability to forecast the effectiveness of  novel 
drug compounds and pinpoint potential antibacterial 
agents, thereby expediting the creation of  new treatments. 

Prevention and Control
Early outbreak detection: AI is able to scrutinize extensive 
datasets to detect early signs of  bacterial infection 
epidemics, facilitating prompt preventative measures.
Example: Machine learning algorithms can assess the 
likelihood of  severe sepsis in ICU patients, notifying 
healthcare professionals and allowing for proactive 
treatment. 

Infection Control in Healthcare Facilities
AI can evaluate data regarding patient and staff  interactions 
to comprehend the transmission of  infections, supporting 
the formulation of  targeted infection control strategies

Challenges and Ethical Considerations
Data quality and quantity: For AI models to be effective, 
they necessitate extensive and high-quality datasets. 

Model Interpretability
It is essential to comprehend how AI algorithms arrive 
at decisions in order to foster trust and guarantee 
responsible usage. 

Ethical Concerns
Issues such as patient privacy, algorithmic bias, and data 



Pa
ge

 
69

https://journals.e-palli.com/home/index.php/ajmsi

Am. J. Med. Sci. Innov. 4(2) 53-72, 2025

security must be tackled to ensure the equitable and 
ethical implementation of  AI.

Future Directions
Interdisciplinary Collaboration
Integrating AI with additional technologies such as 
synthetic biology and nanomedicine has the potential to 
yield more effective strategies for addressing antibiotic 
resistance and various infectious diseases.

Continued Innovation
Persistent research and advancement in AI algorithms, 
data analysis methods, and hardware will be essential for 
unlocking the complete capabilities of  AI in the fight 
against bacterial infections. 

Discussions
The predominant AI applications utilized in clinical 
environments were largely characterized by Machine 
Learning algorithms (ML), including Logistic Regression 
(LR), Random Forest (RF), Support Vector Machines 
(SVMs), and Decision Trees (DTs). These models were 
mainly employed for pathogen identification, early 
detection of  infections, and risk evaluation of  healthcare-
associated infections (HAIs). This model demonstrated 
the high diagnostic precision of  ML algorithms in 
identifying antibiotic-resistant pathogens, underscoring 
AI’s vital contribution to infection control in healthcare 
environments. The significance of  various AI-enabled 
applications in infection control, with the potential to 
improve diagnostic accuracy, optimizes workflows, and 
mitigates the transmission of  infectious diseases. Several 
research efforts have employed advanced AI tools, 
including L2-regularized Logistic Regression models, 
to enhance clinical decision-making in the realm of  
infection control. Within clinical environments, AI aids 
in alleviating the impact of  HAIs by delivering precise, 
real-time predictions and diagnostics, while also propelling 
research into innovative infection control techniques and 
therapeutic approaches. These consistent results emphasize 
the transformative capabilities of  AI across different areas 
of  infection control, in line with the goals and expected 
results of  the scoping review. The incorporation of  
sophisticated AI systems, whether through Machine 
Learning, Deep Learning, or hybrid methodologies, is 
essential in improving the efficacy of  infection prevention 
and control initiatives, ultimately leading to enhanced 
public health outcomes on a global scale.

Summary
With the AI tools we can get multiply of  benefits as a 
result 

Properly Identification of  Pathogen: AI algorithms can 
accurately identify bacterial pathogens therefore, reducing 
diagnostic time and improving treatment accuracy. 

Early Detection of  Antimicrobial Resistance: AI can 
analyze genomic data to identify resistance early thus, 
enabling timely and targeted interventions. 

Tailored Treatment: AI-powered tools help to select 
the antibiotics for individual patients, optimizing 
treatment outcomes and minimizing the risk of  resistance 
development. 

Monitoring the response: AI can be used for surveillance 
and monitoring of  infectious diseases, facilitating early 
outbreak detection and rapid response. 

AI-Assisted Imaging: AI algorithms can analyze 
medical images (like X-rays and CT scans) to aid in 
diagnosis, particularly in cases like COVID-19, where 
early identification and isolation are crucial. 

Improved Diagnostic Precision: AI models have shown 
high accuracy in diagnosing various, enhancing clinical 
decision-making. 

CONCLUSION
AI have a significant promise for revolutionizing 
bacterial infection diagnosis and treatment by improving 
efficiency, accuracy, and personalized medicine 
approaches. However, addressing ethical concerns 
related to data privacy, algorithmic biases and healthcare 
outcomes. With the aid of  AI imaging identification 
and diagnosis of  bacteria can easily notify, help in 
choosing the appropriate antibiotics in the bacterial 
infection. Utilizing advanced technologies like machine 
learning and deep learning, AI has been implemented 
in several critical domains, ranging from swift pathogen 
detection and antimicrobial susceptibility assessment to 
the analysis of  intricate genomic data and the creation 
of  tailored treatment strategies. Through highly refined 
algorithms, AI technology not only significantly enhances 
the speed and precision of  pathogen identification but 
also accurately forecasts the susceptibility of  pathogens 
to particular antibiotics based on historical data, thereby 
offering robust scientific decision support for healthcare 
professionals. Likewise, in the realm of  epidemiological 
surveillance, AI bolstered the capacity for real-time 
monitoring and early warning regarding the spread of  
bacterial infectious diseases by analyzing and processing 
vast amounts of  epidemiological data, thus providing a 
powerful analytical tool and foundation for public health 
decision-making.  With the assistance of  AI, healthcare 
professionals will be more adept at tackling the challenges 
presented by bacterial infections, further propelling 
medical practice towards enhanced precision, efficiency, 
and personalization, ultimately striving to provide the 
highest quality of  care and treatment for patients.

REFERENCES
Abbasi, B. A., Saraf, D., Sharma, T., Sinha, R., Singh, 

S., Sood, S., et al. (2022). Identification of  vaccine 
targets & design of  vaccine against SARS-CoV-2 
coronavirus using computational and deep learning-
based approaches. PeerJ, 10, e13380. https://doi.
org/10.7717/peerj.13380

Abu-Aqil, G., Lapidot, I., Salman, A., & Huleihel, M. 
(2023). Quick detection of  Proteus and Pseudomonas 
in patients’ urine and assessing their antibiotic 



Pa
ge

 
70

https://journals.e-palli.com/home/index.php/ajmsi

Am. J. Med. Sci. Innov. 4(2) 53-72, 2025

susceptibility using infrared spectroscopy and 
machine learning. Sensors, 23(8132). https://doi.
org/10.3390/s23198132

Adams, C., Beller, E., Clark, J., & Tsafnat, G. (n.d.). Making 
progress with the automation of  systematic reviews: Principles 
of  the International Collaboration for the Automation of  
Systematic Reviews (ICASR). 

Aggarwal, S., Dhall, A., Patiyal, S., Choudhury, S., Arora, 
A., & Raghava, G. P. S. (2023). An ensemble method 
for prediction of  phage-based therapy against bacterial 
infections. Frontiers in Microbiology, 14, 1148579. 
https://doi.org/10.3389/fmicb.2023.1148579

Alami, H., Lehoux, P., Denis, J.-L., Motulsky, A., 
Petitgand, C., & Savoldelli, M. (2020). Organizational 
readiness for artificial intelligence in health care: 
Insights for decision-making and practice. Journal 
of  Health Organization and Management, 35, 106–114. 
https://doi.org/10.1108/JHOM-03-2020-0074

Aljaaf, A. J., Al-Jumeily, D., Hussain, A. J., Fergus, P., Al-
Jumaily, M., & Abdel-Aziz, K. (n.d.). Toward an optimal 
use of  artificial intelligence techniques within a clinical decision 
support system. 

American Society for Microbiology. (2016). Biochemical 
tests for the identification of  aerobic bacteria. In Clinical 
Microbiology Procedures Handbook (Vol. 3.17.1.1–3.17.48.3). 
https://doi.org/10.1128/9781555818814.ch3.17.1

Andrews, D., Chetty, Y., Cooper, B. S., Virk, M., Glass, 
S. K., Letters, A., Kelly, P. A., Sudhanva, M., & 
Jeyaratnam, D. (2017). Multiplex PCR point of  care 
testing versus routine, laboratory-based testing in the 
treatment of  adults with respiratory tract infections: 
A quasi-randomised study assessing impact on length 
of  stay and antimicrobial use. BMC Infectious Diseases, 
17, 671. https://doi.org/10.1186/s12879-017-2784-z

Avni, T., Bieber, A., Green, H., Steinmetz, T., Leibovici, 
L., & Paul, M. (2016). Diagnostic accuracy of  PCR 
alone and compared to urinary antigen testing for 
detection of  Legionella spp.: A systematic review. 
Journal of  Clinical Microbiology, 54(2), 401–411. https://
doi.org/10.1128/JCM.02675-15

Baggett, H. C., Rhodes, J., Dejsirilert, S., Salika, P., 
Wansom, T., Jorakate, P., Kaewpan, A., Olsen, S. J., 
Maloney, S. A., & Peruski, L. F. (2012). Pneumococcal 
antigen testing of  blood culture broth to enhance the 
detection of  Streptococcus pneumoniae bacteremia. 
European Journal of  Clinical Microbiology & Infectious 
Diseases, 31(5), 753–756. https://doi.org/10.1007/
s10096-011-1370-3

Baker, J., Timm, K., Faron, M., Ledeboer, N., & 
Culbreath, K. (2020). Digital image analysis for the 
detection of  group B Streptococcus from ChromID 
Strepto B medium using PhenoMatrix algorithms. 
Journal of  Clinical Microbiology, 59, e01902-19. https://
doi.org/10.1128/JCM.01902-19

Bean, H. D. (2012). Bacterial volatile discovery using 
solid-phase microextraction and comprehensive two-
dimensional gas chromatography–time-of-flight mass 
spectrometry. Journal of  Chromatography B: Analytical 

Technologies in the Biomedical and Life Sciences. https://
doi.org/10.1016/j.jchromb.2012.03.021

Berke, A., & Tilton, R. C. (1986). Evaluation of  
rapid coagulase methods for the identification of  
Staphylococcus aureus. Journal of  Clinical Microbiology, 
23, 916–919.

Bilgin, G. B., Bilgin, C., Burkett, B. J., Orme, J. J., Childs, D. 
S., & Thorpe, M. P. (2024). Theranostics and artificial 
intelligence: New frontiers in personalized medicine. 
Theranostics, 14, 2367–2378. https://doi.org/10.7150/
thno.94788

Burkovski, A. (2022). Host–pathogen interaction 3.0. 
International Journal of  Molecular Sciences, 23, 12811. 
https://doi.org/10.3390/ijms232112811

Cath, C. (2018). Governing artificial intelligence: Ethical, 
legal and technical opportunities and challenges. 
Philosophical Transactions of  the Royal Society A: 
Mathematical, Physical and Engineering Sciences, 376(2133), 
20180080. https://doi.org/10.1098/rsta.2018.0080

Centers for Disease Control and Prevention. (2022). 
COVID-19: U.S. Impact on antimicrobial resistance, special 
report 2022. https://doi.org/10.15620/cdc:117915

Cheng, J., & Druzdzel, M. J. (2000). AIS-BN: An adaptive 
importance sampling algorithm for evidential 
reasoning in large Bayesian networks. Journal of  
Artificial Intelligence Research, 13, 155–188. https://doi.
org/10.1613/jair.650

Cherkaoui, A., Renzi, G., Charretier, Y., Blanc, D. S., 
Vuilleumier, N., & Schrenzel, J. (2019). Automated 
incubation and digital image analysis of  chromogenic 
media using Copan WASPLab enables rapid detection 
of  vancomycin-resistant Enterococcus. Frontiers in 
Cellular and Infection Microbiology, 9, 379. https://doi.
org/10.3389/fcimb.2019.00379

Cisek, A. A., Dąbrowska, I., Gregorczyk, K. P., & Wyżewski, 
Z. (2017). Phage therapy in bacterial infections 
treatment: One hundred years after the discovery of  
bacteriophages. Current Microbiology, 74(3), 277–283. 
https://doi.org/10.1007/s00284-016-1166-x

Couturier, M. R., Graf, E. H., & Griffin, A. T. 
(2014). Urine antigen tests for the diagnosis of  
respiratory infections: Legionellosis, histoplasmosis, 
pneumococcal pneumonia. Clinical Laboratory 
Medicine, 34(2), 219–236. https://doi.org/10.1016/j.
cll.2014.02.002

D’Haen, J. (n.d.). Integrating expert knowledge and multilingual 
web crawling data in a lead qualification system. 

Deelder, W., Napier, G., Campino, S., Palla, L., Phelan, 
J., & Clark, T. G. (2022). A modified decision tree 
approach to improve the prediction and mutation 
discovery for drug resistance in Mycobacterium 
tuberculosis. BMC Genomics, 23, 46. https://doi.
org/10.1186/s12864-022-08291-4

Deusenbery, C., Wang, Y., & Shukla, A. (2021). Recent 
innovations in bacterial infection detection and 
treatment. ACS Infectious Diseases, 7(3), 695–720. 
https://doi.org/10.1021/acsinfecdis.0c00890

Dou, X., Yang, F., Wang, N., Xue, Y., Hu, H., & Li, B. 



Pa
ge

 
71

https://journals.e-palli.com/home/index.php/ajmsi

Am. J. Med. Sci. Innov. 4(2) 53-72, 2025

(2023). Rapid detection and analysis of  Raman spectra 
of  bacteria in multiple fields of  view based on image 
stitching technique. Frontiers in Bioscience-Landmark, 28, 
249. https://doi.org/10.31083/j.fbl2810249

Dwivedi, Y. K., Hughes, D. L., Coombs, C., Constantiou, 
I., Duan, Y., Edwards, J. S., Gupta, B., Lal, B., Misra, 
S., Prashant, P., & Raman, R. (2020). Impact of  
COVID-19 pandemic on information management 
research and practice: Transforming education, 
work and life. International Journal of  Information 
Management, 55, 102211. https://doi.org/10.1016/j.
ijinfomgt.2020.102211

Ekins, S., Godbole, A. A., Kéri, G., Orfi, L., Pato, 
J., & Bhat, R. S. (2017). Machine learning and 
docking models for Mycobacterium tuberculosis 
topoisomerase I. Tuberculosis (Edinburgh), 103, 52–60. 
https://doi.org/10.1016/j.tube.2017.01.005

Ernst, D., Bolton, G., Recktenwald, D., Cameron, M. J., 
Danesh, A., & Persad, D. (2006). Bead-based flow 
cytometric assays: A multiplex assay platform with 
applications in diagnostic microbiology. In Advanced 
Techniques in Diagnostic Microbiology (pp. 427–443). Springer 
US. https://doi.org/10.1007/978-0-387-32892-4_23

Gilbert, G. L., & Kerridge, I. (2020). Hospital infection 
prevention and control (IPC) and antimicrobial 
stewardship (AMS): Dual strategies to reduce 
antibiotic resistance (ABR) in hospitals. In Ethics and 
drug resistance: Collective responsibility for global public health 
(pp. 89–108). Springer. https://doi.org/10.1007/978-
3-030-27874-8_6

Goodswen, S. J., Barratt, J. L. N., Kennedy, P. J., Kaufer, 
A., Calarco, L., & Ellis, J. T. (2021). Machine learning 
and applications in microbiology. FEMS Microbiology 
Reviews, 45(3), fuab015. https://doi.org/10.1093/
femsre/fuab015

Ho, C.-S., Jean, N., Hogan, C. A., Blackmon, L., Jeffrey, 
S. S., & Holodniy, M. (2019). Rapid identification 
of  pathogenic bacteria using Raman spectroscopy 
and deep learning. Nature Communications, 10, 4927. 
https://doi.org/10.1038/s41467-019-12898-9

Howard, A., Aston, S., Gerada, A., Reza, N., Bincalar, J., 
& Mwandumba, H. (2024). Antimicrobial learning 
systems: An implementation blueprint for artificial 
intelligence to tackle antimicrobial resistance. The 
Lancet Digital Health, 6(2), e79–e86. https://doi.
org/10.1016/S2589-7500(23)00221-2

Hummel, P., & Braun, M. (2020). Just data? Solidarity and 
justice in data-driven medicine. Life Sciences, Society and 
Policy, 16, 8. https://doi.org/10.1186/s40504-020-
00101-7

Hutchinson, D., Kunasekaran, M., Quigley, A., Moa, A., 
& MacIntyre, C. R. (2023). Could it be Monkeypox? 
Use of  an AI-based epidemic early warning system to 
monitor rash and fever illness. Public Health, 220, 142–
147. https://doi.org/10.1016/j.puhe.2023.05.010

Kassis, C., Zaidi, S., Kuberski, T., Moran, A., Gonzalez, 
O., & Hussain, S. (2015). Role of  Coccidioides antigen 
testing in the cerebrospinal fluid for the diagnosis of  

coccidioidal meningitis. Clinical Infectious Diseases, 61(10), 
1521–1526. https://doi.org/10.1093/cid/civ585

Kaufmann, E., Chacon, A., Kausel, E. E., Herrera, N., 
& Reyes, T. (2023). Task-specific algorithm advice 
acceptance: A review and directions for future 
research. Data and Information Management, 7(1), 
100040. https://doi.org/10.1016/j.dim.2023.100040

Khaledi, A., Schniederjans, M., Pohl, S., Rainer, R., 
Bodenhofer, U., & Xia, B. Y. (n.d.). Transcriptome profiling 
of  antimicrobial resistance in Pseudomonas aeruginosa. 

King, K. P. (2009). The handbook of  the evolving research of  
transformative learning: Based on the Learning Activities 
Survey. Information Age Publishing.

Kotsiantis, S. B. (2007). Supervised machine learning: 
A review of classification techniques. Informatica, 31, 
249–268. 

Ledro, C., Nosella, A., & Vinelli, A. (2022). Artificial 
intelligence in customer relationship management: 
Literature review and future research directions. 
Journal of  Business & Industrial Marketing, 37(13), 48–
63. https://doi.org/10.1108/JBIM-02-2021-0092

Liu, G. (2023). Deep learning-guided discovery of  
an antibiotic targeting Acinetobacter baumannii. 
Nature Chemical Biology, 19, 1342–1350. https://doi.
org/10.1038/s41589-023-01349-8

Miner, A. S. (2020). Chatbots in the fight against the 
COVID-19 pandemic. NPJ Digital Medicine, 3, 65. 
https://doi.org/10.1038/s41746-020-0280-0

Mintz, Y., & Brodie, R. (2019). Introduction to artificial 
intelligence in medicine. Minimally Invasive Therapy & 
Allied Technologies, 28(2), 73–81. https://doi.org/10.10
80/13645706.2019.1575864

Mizuno, S., Iwami, M., Kunisawa, S., Naylor, N., 
Yamashita, K., Kyratsis, Y., et al. (2018). Comparison 
of  national strategies to reduce meticillin-resistant 
Staphylococcus aureus infections in Japan and 
England. Journal of  Hospital Infection, 100(3), 280–298. 
https://doi.org/10.1016/j.jhin.2018.06.026

Oh, J. (2018); Tilton, S. C., & Johnson, M. (2019). 
Assessing susceptibility for polycyclic aromatic 
hydrocarbon toxicity in an in vitro 3D respiratory 
model for asthma. 

Oh, J., Makar, M., Fusco, C., McCaffrey, R., Rao, K., 
& Ryan, E. E. (2018). A generalizable, data-driven 
approach to predict daily risk of  Clostridium difficile 
infection at two large academic health centers. Infection 
Control & Hospital Epidemiology, 39(4), 425–433. 
https://doi.org/10.1017/ice.2018.16

Østerlund, C., Jarrahi, M. H., Willis, M., Boyd, K., & 
Wolf, C. T. (2021). Artificial intelligence and the world 
of  work: A co-constitutive relationship. Journal of  the 
Association for Information Science and Technology, 72(1), 
128–135. https://doi.org/10.1002/asi.24420

Paquin, P., Durmort, C., Paulus, C., Vernet, T., Marcoux, 
P. R., & Morales, S. (2022). Spatio-temporal based 
deep learning for rapid detection and identification of  
bacterial colonies through lens-free microscopy time-
lapses. PLOS Digital Health, 1(1), e0000122. https://



Pa
ge

 
72

https://journals.e-palli.com/home/index.php/ajmsi

Am. J. Med. Sci. Innov. 4(2) 53-72, 2025

doi.org/10.1371/journal.pdig.0000122
Pentina, I., Xie, T., Hancock, A., & Bailey, A. (2023). 

Consumer–machine relationships in the age of  
artificial intelligence: Systematic literature review and 
research directions. Psychology & Marketing. https://
doi.org/10.1002/mar.22042

Perkins, M. D., Mirrett, S., & Reller, L. B. (1995). Rapid 
bacterial antigen detection is not clinically useful. 
Journal of  Clinical Microbiology, 33(6), 1486–1491. 
https://doi.org/10.1128/jcm.33.6.1486-1491.1995

Porcel, J. M. (2018). Biomarkers in the diagnosis of  
pleural diseases: A 2018 update. Therapeutic Advances 
in Respiratory Disease, 12, 1753466618808660. https://
doi.org/10.1177/1753466618808660

Rahman, T., Khandakar, A., Rahman, A., Zughaier, S. 
M., Al Maslamani, M., Chowdhury, M. H., Tahir, 
A. M., Hossain, M. S. A., & Chowdhury, M. E. H. 
(2024). TB-CXRNet: Tuberculosis and drug-resistant 
tuberculosis detection technique using chest X-ray 
images. Cognitive Computation, 16, 1393–1412. https://
doi.org/10.1007/s12559-023-10267-7

Rees, C., & Müller, B. (2022). All that glitters is not gold: 
Trustworthy and ethical AI principles. AI and Ethics, 
3(3), 1241–1254. https://doi.org/10.1007/s43681-
022-00232-x

Srivastava, B., & Rossi, F. (2019). Rating AI systems for bias 
to promote trustable applications. 

Talaei-Khoei, A., Yang, A. T., & Masialeti, M. (2024). How 
does incorporating ChatGPT within a firm reinforce 

agility-mediated performance? The moderating role 
of  innovation infusion and firms’ ethical identity. 
Technovation, 132, 102975. https://doi.org/10.1016/j.
technovation.2023.102975

Venkatachalam, S., & Ray, A. (2022). How do context-
aware artificial intelligence algorithms used in fitness 
recommender systems? A literature review and 
research agenda. Journal of  Innovation & Knowledge 
in Emerging Markets. https://doi.org/10.1016/j.
jjimei.2022.100139

Viasus, D., Calatayud, L., McBrown, M. V., Ardanuy, 
C., & Carratalà, J. (2019). Urinary antigen testing in 
community-acquired pneumonia in adults: An update. 
Expert Review of  Anti-Infective Therapy, 17(2), 107–115. 
https://doi.org/10.1080/14787210.2019.1565994

Walker, D. H. (2014). Principles of  diagnosis of  infectious 
diseases. In Pathobiology of  human disease (pp. 222–225). 
Amsterdam, The Netherlands: Elsevier.

Wan, F. (2024). Deep-learning-enabled antibiotic discovery through 
molecular de-extinction. Nature Biomedical Engineering. 
https://doi.org/10.1038/s41551-024-01201-x

Wong, F. (2023). Leveraging artificial intelligence in the 
fight against infectious diseases. Science, 381(6653), 
164–170. https://doi.org/10.1126/science.abq4000

Zulderwijk, A. (2021). Implications of  the use of  artificial 
intelligence in public governance: A systematic 
literature review and a research agenda. Government 
Information Quarterly, 38(3), 101577. https://doi.
org/10.1016/j.giq.2021.101577


